Neoteryx

What Neoteryx does

Neoteryx is a Torrance, California-based medical device company that develops and commercializes microsampling devices for remote, at-home collection of biological fluids. Founded in 2014 as a spin-off from Phenomenex Inc. and now operating as the microsampling brand of Trajan Scientific and Medical (legal entity: Trajan Scientific Americas Inc.), the company builds on patented Volumetric Absorptive Microsampling (VAMS) technology, which uses absorptive polymer tips to collect fixed, hematocrit-independent volumes of capillary blood (up to 120 µL) that can be dried and shipped by standard mail without cold-chain logistics. Its product portfolio spans the Mitra blood microsampler, the GenTegraRNA-NEO RNA stabilization chemistry (exclusive to Mitra), the Harpera suture-free skin microbiopsy punch (FDA-registered), the hemaPEN next-generation dried blood spot device (CE-IVD registered in EU/UK/AU/NZ/USA), and the CHRONECT automated workstation for population-scale PFAS biomonitoring.

The company sells directly to research institutions, pharmaceutical companies, clinical laboratories, and healthcare organizations, supplemented by regional authorized distributors (e.g., AppMed Inc. for Canada) and a network of technology integration partners (Cellecta, Metabolon, Promega, GenTegra) that bundle Mitra devices into validated kits and workflows. Pricing is quote-based and not publicly disclosed, with sales supported by Microsampling Specialists. Target customer segments include pharmaceutical and CRO buyers for decentralized clinical trials and therapeutic drug monitoring, academic and medical research institutions for omics and precision medicine, environmental and public health organizations for biomonitoring, healthcare and diagnostic laboratories for TDM and toxicology, preclinical animal research groups, and pediatric or hard-to-reach patient populations. The platform is used in research across 78 countries and by over 900 laboratories, supported by more than 1,000 peer-reviewed publications validating the technology.

Name

Neoteryx

Legal name

Trajan Scientific Americas Inc.

Website

https://neoteryx.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Neoteryx, the microsampling brand of Trajan Scientific and Medical, develops VAMS-based blood and skin microsampling devices (Mitra, Harpera, hemaPEN, CHRONECT) that enable remote, volumetrically precise dried-sample collection for pharmaceutical, CRO, academic, clinical, and environmental research customers worldwide.

Ownership category

akta.pro rank

Product category

Microsampling Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• Volumetric microsampling devices
• Dried blood spot collection
• Biological specimen sampling
• Remote clinical trial sampling
• Skin microbiopsy tools

Headquarters

HQ city

Torrance

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Microsampling Device Sales: Neoteryx generates revenue primarily through the sale of its microsampling devices, including Mitra (VAMS-based), Harpera (skin microbiopsy), hemaPEN (DBS next-gen), and associated耗材 and kits. Devices are sold directly and through authorized distributors globally.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels9 records

Core offering

Neoteryx designs, manufactures, and commercializes microsampling devices and consumables based on its patented Volumetric Absorptive Microsampling (VAMS) technology. Its flagship Mitra device enables volumetrically accurate, hematocrit-independent collection of capillary blood and other biological fluids via finger-prick, which can then be shipped by standard mail without cold-chain logistics. The portfolio is extended with RNA stabilization reagents, a suture-free skin microbiopsy punch, a CE-IVD dried blood spot pen, and automated PFAS analysis workstations.

Product overview

Neoteryx, a Trajan Scientific and Medical company, offers a unified microsampling product portfolio centered on its patented VAMS (Volumetric Absorptive Microsampling) technology. The core offering is the Mitra microsampling device, which uses VAMS tips to collect precise volumes (up to 120 µL) of capillary blood via finger-prick. This core device is complemented by the GenTegraRNA-NEO RNA stabilization solution for room-temperature sample preservation, the CHRONECT automated workstation for PFAS analysis workflows, and the Harpera Microbiopsy Punch for scarless skin biopsies. The hemaPEN provides an alternative dried blood spot format. These products work together to enable remote, at-home sample collection that eliminates cold-chain shipping requirements and reduces patient burden compared to traditional venipuncture.

Differentiator

Problem solved

Functional benefit

Brands

• Mitra: Mitra microsampling devices using VAMS (Volumetric Absorptive Microsampling) technology for collecting biological fluid samples.
• Harpera
• hemaPEN
• CHRONECT
• GenTegraRNA-NEO

Products and services

• Mitra with VAMS Microsampling Device Patented microsampling device using VAMS technology to volumetrically absorb up to 120 µL of capillary blood via finger-prick, providing hematocrit-independent fixed-volume sampling that can be shipped by standard mail without cold chain. Designed for pharmaceutical research, clinical trials, academic omics studies, therapeutic drug monitoring, and population biomonitoring.
• GenTegraRNA-NEO Stabilization Solution Active Chemical Protection (ACP) stabilization solution pre-applied to Mitra devices to stabilize and preserve RNA in dried blood samples for up to 7 days at room temperature, eliminating cold-chain logistics for RNA-based studies. Distributed by Neoteryx under partnership with GenTegra LLC.
• Harpera Microbiopsy Punch Suture-free, virtually painless microbiopsy punch that enables minimally invasive scarless collection of skin specimens for dermatology and skin research. FDA-registered for marketing in the US and available as Investigational Use Only (IUO) outside the US.
• hemaPEN Dried Blood Spot Collection Device Next-generation dried blood spot sampling device based on CE-IVD (IVDR) registered technology, available as a registered IVD device in the EU, UK, Australia/New Zealand, and the USA for specimen collection, storage, and transport of dried blood specimens.
• CHRONECT Automated Workstation Automated workstation that, when paired with Mitra microsampling devices using VAMS technology, offers a fully integrated solution for PFAS analysis in population-scale biomonitoring and clinical workflows.

Quantifiable outcome

• 99% sample acceptance rate for homogeneous samples when study participants follow instructions and demo videos
• +5 more outcomes

Named customers17 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core, flagship and minor.

• AppMed Inc.coreChannel Partner/ Reseller/ Distributor · 3 December 2025Trajan appointed AppMed Inc. as the Canadian distributor for microsampling technologies, featuring Mitra® and Harpera® devices. This appointment extends Neoteryx's market reach in Canada through a dedicated channel partner for research-use and clinical products.
• Cellecta, Inc.flagshipTechnology or Integration · 14 May 2025Neoteryx partnered with Cellecta to introduce the DriverMap EXP Human Genome-Wide 19K Dried Blood Microsample Profiling Kit, combining Cellecta's DriverMap EXP targeted RNA sequencing with Neoteryx's Mitra microsampling devices pre-treated with GenTegraRNA-NEO. This enables analysis of all 19,000 human protein-coding genes from a 30 µL finger-prick blood sample. The kit is available in 24 or 96 sample configurations.
• Promega CorporationcoreTechnology or Integration · 18 April 2024Promega published an application note demonstrating automated RNA purification from whole blood collected on Mitra devices using the Promega Maxwell RSC simplyRNA Blood Kit and Maxwell RSC Instrument. This integration enables labs to automate RNA purification from dried blood microsamples, streamlining workflows for RNA-based studies.
• MetaboloncoreTechnology or IntegrationMetabolon and Trajan collaborated to offer microsampling for metabolomics studies. Metabolon validated a method for metabolomic profiling in blood microsamples collected using Trajan's Neoteryx Mitra device based on VAMS technology. Mitra devices paired with Metabolon's Global Discovery Panel enable precise metabolomic analysis in remotely collected blood samples.
• IQVIA LaboratoriescoreStrategic or Co-development PartnerTrajan Scientific and Medical and IQVIA Laboratories co-hosted a webinar examining how blood microsampling is reshaping clinical trial design to enhance patient convenience, operational flexibility, and access. The collaboration highlights microsampling's role in supporting more patient-centric decentralized clinical trials.
• GenTegra LLCcoreTechnology or IntegrationNeoteryx distributes GenTegraRNA-NEO, an Active Chemical Protection (ACP) RNA stabilization technology developed by GenTegra for exclusive use with Mitra microsampling devices. GenTegraRNA-NEO stabilizes RNA in blood samples for up to 7 days at room temperature, enabling remote RNA-based studies without cold-chain logistics.
• NC3Rs (National Centre for the Replacement, Refinement & Reduction of Animals in Research)minorGTM or Marketing PartnerNC3Rs provided a video demonstrating blood collection from a rat using a tail-stick method and Mitra microsampling device as part of its microsampling resources. The video supports the adoption of microsampling to achieve the 3Rs (Replace, Reduce, Refine) in animal research. Neoteryx hosts this content on its website as a promotional and educational resource.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• QIAGEN: Global life science tools and molecular diagnostics company offering sample collection and nucleic acid stabilization technologies (e.g., QIAcard FTA, PAXgene). Overlaps with Neoteryx in pre-analytical workflows but as part of a much broader portfolio.
• Bio-Rad Laboratories: Clinical diagnostics and life science research company offering sample collection, quality controls, and bioanalytical tools. Serves overlapping customers in clinical research labs but as a broad-line incumbent rather than microsampling specialist.
• PerkinElmer: Diversified diagnostics, life sciences, and applied services company with dried blood spot screening and sample collection products used in newborn screening and clinical research. Adjacent competitor with significantly broader portfolio scale.
• Becton Dickinson (BD): Global medical device leader in specimen collection (vacuum blood tubes, capillary devices) and diagnostics. Overlaps with Neoteryx at the pre-analytical collection step for clinical and research customers.

Others

• Metabolon: Metabolomics services and analytics company that has validated Mitra as the upstream collection device for its Global Discovery Panel. Adjacent ecosystem partner rather than a direct competitor.

Direct peers

• HemaXis (STRATEC): Swiss-origin DBS microsampling device developer (acquired by STRATEC). Targets the same fixed-volume capillary blood sampling need for decentralized trials and bioanalytical workflows as Neoteryx's Mitra.
• Yourbio Health: Developer of the TAP (Touch Activated Phlebotomy) capillary blood collection device for virtually painless, patient-friendly sample collection. Direct competitor to Neoteryx in the home-based and decentralized sampling category.
• Capitainer: Swedish developer of the Capitainer qDBS quantitative dried blood spot microsampling device. Competes directly with Mitra on volumetric accuracy and home-based sample collection for research and clinical applications.
• Tasso Inc. Tasso develops OnDemand and Tasso+ capillary blood microsampling devices that enable patient self-collection of dried blood at home. It is the most direct functional competitor to Mitra, targeting the same decentralized clinical trial and remote sampling use cases.
• Cytiva (formerly GE Healthcare Life Sciences / Whatman): Through the Whatman brand, Cytiva supplies the classic 903 and FTA dried blood spot cards that remain the incumbent format Neoteryx's Mitra is designed to displace. They compete for the same research and bioanalytical sample collection budgets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/neoteryx
• LinkedInlinkedin.com/company/neoteryx

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neoteryx